KELOWNA, BC – Lexaria Bioscience Corp, a global innovator in drug delivery platforms, announced that it has entered into a definitive agreement for the purchase and sale of an aggregate… Read More
SAN FRANCISCO and VANCOUVER, BC — Jade Biosciences Inc, a clinical-stage biotechnology company focused on developing best-in-class therapies for autoimmune diseases, announced that it has entered into a securities purchase… Read More
FRANKLIN LAKES, NJ – BD (Becton, Dickinson and Company), a leading global medical technology company, announced the expansion of its respiratory and sexually transmitted infection (STI) diagnostics offerings in Europe following… Read More
Amsterdam, NL – argenx, a global immunology company committed to improving the lives of people suffering from severe autoimmune diseases, announced that the Phase 3 UplighTED studies evaluating efgartigimod subcutaneous… Read More
The Road to Recovery (R2R) program, a new model of substance use treatment, is helping to shape the future of addiction care across B.C. Co-led by Dr. Brittany Dennis, Clinician-Scientist,… Read More
